2m 2m 2m 2m 2m 2m 2m
XERIS BIPH HLDG (XERS)
NASDAQ
$9.17-$0.09 (-0.92%)
Price as of Oct 02, 2026 5:49 PM EDT- $1.7BMarket Cap
- 11.31%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
XERIS BIPH HLDG (XERS)
$9.17-$0.09 (-0.92%)
XERS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.25 | ||
Change | -$0.31 (-3.24%) | ||
Open | $9.52 | ||
High | $9.69 | ||
Low | $9.18 | ||
Previous Close | $9.56 | ||
Volume | 3,591,099 | ||
30-Day Average Volume | 3,078,392 | ||
1-Week Change | 3.35% | ||
1-Month Change | 9.73% | ||
1-Year Change | 11.31% | ||
3-Year Change | 397.31% | ||
5-Year Change | 274.49% | ||
Fundamentals | |||
Shares Outstanding | 182.3M | ||
Total Assets | $411.9M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $91.0M | ||
Net Income | -$31.1M | ||
Free Cash Flow | $8.5M | ||
EBIT | -$31.1M | ||
EBITDA | -$28.4M | ||
Net Working Capital | $85.2M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -64 | ||
Enterprise Value/Revenue | 20 | ||
P/B | -173 | ||
P/E | -51 | ||
PEG | 0 | ||
Price/Free Cash Flow | 199 | ||
Price/Operating Cash Flow | 204 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue